Cartoon depicting a large collection of micrographs hovering over a computer chip

Progress at last against RSV

The approval of two vaccines and a monoclonal antibody that target respiratory syncytial virus could shift the tide on the prevention and treatment of infection with this virus.



  • People of different ages and backgrounds coming together to form a healthy population

    Nature Medicine presents a special Focus dedicated to population health in the context of new threats and growing inequities. This includes a variety of news, opinion, reviews and original research on critical areas and challenges that must be addressed in order to build healthy communities and deliver on the commitments of the SDGs.

  • evidence in medicine

    New therapeutics and health technologies require fresh approaches to demonstrating safety and efficacy. This collection brings together key stakeholders to discuss how evidence-based medicine should evolve to assess these technological advances, from gene editing to artificial intelligence health algorithms.

  • Crab, the avatar of cancer.

    Read about the latest advances in translational and clinical research, selected by the Nature Medicine editorial team.

Nature Medicine is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.


Nature Careers